Tecadenoson manufacturers
- Tecadenoson
-
- $46.00 / 1mg
-
2024-11-19
- CAS:204512-90-3
- Min. Order:
- Purity: 99.76%
- Supply Ability: 10g
|
| | Tecadenoson Basic information |
| Product Name: | Tecadenoson | | Synonyms: | Adenosine, N-[(3R)-tetrahydro-3-furanyl]-;N6-[3(R)-Tetrahydrofuranyl]adenosine;(2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-(((R)-tetrahydrofuran-3-yl)amino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol;CVT-510;Inhibitor,P1 receptor,Tecadenoson,Adenosine Receptor,CVT510,CVT 510,inhibit;Tecadenoso | | CAS: | 204512-90-3 | | MF: | C14H19N5O5 | | MW: | 337.33 | | EINECS: | | | Product Categories: | | | Mol File: | 204512-90-3.mol |  |
| | Tecadenoson Chemical Properties |
| Boiling point | 704.9±70.0 °C(Predicted) | | density | 1.89±0.1 g/cm3(Predicted) | | storage temp. | 2-8°C(protect from light) | | solubility | DMF: 30 mg/ml; DMSO: 30 mg/ml; Ethanol: Partially soluble; PBS (pH 7.2): 3 mg/ml | | form | A crystalline solid | | pka | 13.11±0.70(Predicted) | | color | White to off-white |
| | Tecadenoson Usage And Synthesis |
| Description | Tecadenoson is an analog of adenosine. Tecadenoson works by activating two types of receptors: A1 and A2A. Activation of these receptors leads to increased blood supply, which improves symptoms in patients with chronic obstructive pulmonary disease. Tecadenoson has also been shown to reduce inflammation and improve lung function in animal models of asthma. Tecadenoson is not active against bacterial infections or viral infections, but is effective against autoimmune diseases such as lupus erythematosus, rheumatoid arthritis, and vasculitis. | | Uses | Treatment of paroxysmal supraventricular
tachycardia and rate control in atrial fibrillation
and atrial flutter. | | Uses | Tecadenoson, is a selective A1 adenosine receptor agonist. |
| | Tecadenoson Preparation Products And Raw materials |
|